digital privacy statement.
Genetic targets for inflammatory disease are the focus of new NIH-funded research.
Dr. H. Michael Belmont effectively treats a patient with lupus facing thrombocytopenia and anemia.
The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.
Rheumatology Highlights 2019–2020
Studies explore rheumatoid arthritis medication responses and how psoriatic arthritis develops.
Explore the Issue
We can help you find a doctor.
browse our specialists.